MARCHEBIOBANK is the Collaborative Platform created in the field of personalized medicine: drugs, diagnostics and new therapeutic approaches.

The overall objective of the Regional Platform is to structure and make stable over time a synergistic and effective collaboration between the business world and the research world within the Marche Region on the topic of personalized medicine, drugs, diagnostics and new therapeutic approaches and in particular those for the management of chronic diseases, oncological diseases with high medical need and rare diseases. Translated with (free version)


Funded by: POR MARCHE FESR 2014-2020 ASSE 1 – OS 2 – Azione 2.1
Budget: 10.377.427,21 € [contributo concesso 5.465.367,80 €] Period: 2019/12/12 – 2022/12/12
Duration: 36 months
personalized medicine, drugs and new therapeutic approaches


Diatheva, Bimind, Diatech Pharmacogenetics, Gluos, Mivell, Pharmaprogress, Prosopika, Prosilas, Recusol, Acraf, Università degli Studi di Urbino, Università di Camerino, Università Politecnica Delle Marche, Fondazione Cluster Marche.